Does LVAD implantation improve mitral regurgitation, and does baseline or residual MR influence outcomes?
Patients undergoing left ventricular assist device (LVAD) implantation in the MOMENTUM 3 trial
Left ventricular assist device (LVAD) implantation, specifically the HM3 LVAD
Improvement in clinically significant mitral regurgitation (MR) and post-implantation outcomes
LVAD implantation, particularly with the HM3 device, effectively reduces mitral regurgitation, and neither baseline nor residual MR negatively impacts patient outcomes.
Hemodynamic unloading after LVAD implantation improves clinically significant MR early, sustainably, and to a greater extent with the HM3 LVAD. Neither baseline nor residual MR influence outcomes after LVAD implantation.
Building similarity graph...
Analyzing shared references across papers
Loading...
Manreet Kanwar
Keshava Rajagopal
Akinobu Itoh
The Journal of Heart and Lung Transplantation
Harvard University
Columbia University
Brigham and Women's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Kanwar et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d5724275589c71d767e683 — DOI: https://doi.org/10.1016/j.healun.2020.03.003